Cellular Evidence of Reverse Cardiac Remodeling Induced by Cardiac Resynchronization Therapy

Carlos M. Orrego, Nadim Nasir, Guilherme H. Oliveira, Jose H. Flores-Arredondo, Andrea M. Cordero-Reyes, Matthias Loebe, Keith A. Youker, Guillermo Torre-Amione

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Left ventricular assist devices (LVADs) induce reverse cardiac remodeling by reducing myocyte size and collagen deposition. On the other hand, cardiac resynchronization therapy (CRT) induces reverse cardiac remodeling by improving electromechanical synchronization. The clinical and structural changes produced by CRT in failing myocardium are known, but whether these changes are accompanied by reverse cellular remodeling is unknown. A total of 12 patients with chronic heart failure (CHF) who underwent CRT and 15 patients who had LVAD therapy as clinically indicated and 8 healthy controls were compared. Demographics, echocardiographic data, and histologic samples from myocardial biopsies were analyzed and compared among groups. The authors found significant increases in myocyte size, myocardial fibrosis, and inflammation in both CHF groups who underwent CRT or LVAD, compared with healthy controls. After CRT or LVAD therapy, a significant decrease in myocyte size and tumor necrosis factor α (TNF-α) expression compared with healthy controls (P<05) was found. In the CRT group, 6 of 8 patients demonstrated reduction in myocyte size and interstitial fibrosis. In addition, there was a decrease in myocyte size by 13%, total collagen by 27% and TNF-α by 49% in the CRT group vs 28%, 45%, and 45% in the LVAD group. CRT produces cellular reverse remodeling in failing human hearts that are comparable with those produced by LVAD therapy.

Original languageEnglish (US)
Pages (from-to)140-146
Number of pages7
JournalCongestive Heart Failure
Volume17
Issue number3
DOIs
StatePublished - May 2011
Externally publishedYes

Fingerprint

Cardiac Resynchronization Therapy
Heart-Assist Devices
Muscle Cells
Fibrosis
Collagen
Heart Failure
Tumor Necrosis Factor-alpha
Myocardium
Therapeutics
Demography
Inflammation
Biopsy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Emergency Medicine
  • Emergency

Cite this

Orrego, C. M., Nasir, N., Oliveira, G. H., Flores-Arredondo, J. H., Cordero-Reyes, A. M., Loebe, M., ... Torre-Amione, G. (2011). Cellular Evidence of Reverse Cardiac Remodeling Induced by Cardiac Resynchronization Therapy. Congestive Heart Failure, 17(3), 140-146. https://doi.org/10.1111/j.1751-7133.2011.00227.x

Cellular Evidence of Reverse Cardiac Remodeling Induced by Cardiac Resynchronization Therapy. / Orrego, Carlos M.; Nasir, Nadim; Oliveira, Guilherme H.; Flores-Arredondo, Jose H.; Cordero-Reyes, Andrea M.; Loebe, Matthias; Youker, Keith A.; Torre-Amione, Guillermo.

In: Congestive Heart Failure, Vol. 17, No. 3, 05.2011, p. 140-146.

Research output: Contribution to journalArticle

Orrego, CM, Nasir, N, Oliveira, GH, Flores-Arredondo, JH, Cordero-Reyes, AM, Loebe, M, Youker, KA & Torre-Amione, G 2011, 'Cellular Evidence of Reverse Cardiac Remodeling Induced by Cardiac Resynchronization Therapy', Congestive Heart Failure, vol. 17, no. 3, pp. 140-146. https://doi.org/10.1111/j.1751-7133.2011.00227.x
Orrego, Carlos M. ; Nasir, Nadim ; Oliveira, Guilherme H. ; Flores-Arredondo, Jose H. ; Cordero-Reyes, Andrea M. ; Loebe, Matthias ; Youker, Keith A. ; Torre-Amione, Guillermo. / Cellular Evidence of Reverse Cardiac Remodeling Induced by Cardiac Resynchronization Therapy. In: Congestive Heart Failure. 2011 ; Vol. 17, No. 3. pp. 140-146.
@article{13ed43d31fa34904a1fa9f9d62f24dbe,
title = "Cellular Evidence of Reverse Cardiac Remodeling Induced by Cardiac Resynchronization Therapy",
abstract = "Left ventricular assist devices (LVADs) induce reverse cardiac remodeling by reducing myocyte size and collagen deposition. On the other hand, cardiac resynchronization therapy (CRT) induces reverse cardiac remodeling by improving electromechanical synchronization. The clinical and structural changes produced by CRT in failing myocardium are known, but whether these changes are accompanied by reverse cellular remodeling is unknown. A total of 12 patients with chronic heart failure (CHF) who underwent CRT and 15 patients who had LVAD therapy as clinically indicated and 8 healthy controls were compared. Demographics, echocardiographic data, and histologic samples from myocardial biopsies were analyzed and compared among groups. The authors found significant increases in myocyte size, myocardial fibrosis, and inflammation in both CHF groups who underwent CRT or LVAD, compared with healthy controls. After CRT or LVAD therapy, a significant decrease in myocyte size and tumor necrosis factor α (TNF-α) expression compared with healthy controls (P<05) was found. In the CRT group, 6 of 8 patients demonstrated reduction in myocyte size and interstitial fibrosis. In addition, there was a decrease in myocyte size by 13{\%}, total collagen by 27{\%} and TNF-α by 49{\%} in the CRT group vs 28{\%}, 45{\%}, and 45{\%} in the LVAD group. CRT produces cellular reverse remodeling in failing human hearts that are comparable with those produced by LVAD therapy.",
author = "Orrego, {Carlos M.} and Nadim Nasir and Oliveira, {Guilherme H.} and Flores-Arredondo, {Jose H.} and Cordero-Reyes, {Andrea M.} and Matthias Loebe and Youker, {Keith A.} and Guillermo Torre-Amione",
year = "2011",
month = "5",
doi = "10.1111/j.1751-7133.2011.00227.x",
language = "English (US)",
volume = "17",
pages = "140--146",
journal = "Congestive Heart Failure",
issn = "1527-5299",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Cellular Evidence of Reverse Cardiac Remodeling Induced by Cardiac Resynchronization Therapy

AU - Orrego, Carlos M.

AU - Nasir, Nadim

AU - Oliveira, Guilherme H.

AU - Flores-Arredondo, Jose H.

AU - Cordero-Reyes, Andrea M.

AU - Loebe, Matthias

AU - Youker, Keith A.

AU - Torre-Amione, Guillermo

PY - 2011/5

Y1 - 2011/5

N2 - Left ventricular assist devices (LVADs) induce reverse cardiac remodeling by reducing myocyte size and collagen deposition. On the other hand, cardiac resynchronization therapy (CRT) induces reverse cardiac remodeling by improving electromechanical synchronization. The clinical and structural changes produced by CRT in failing myocardium are known, but whether these changes are accompanied by reverse cellular remodeling is unknown. A total of 12 patients with chronic heart failure (CHF) who underwent CRT and 15 patients who had LVAD therapy as clinically indicated and 8 healthy controls were compared. Demographics, echocardiographic data, and histologic samples from myocardial biopsies were analyzed and compared among groups. The authors found significant increases in myocyte size, myocardial fibrosis, and inflammation in both CHF groups who underwent CRT or LVAD, compared with healthy controls. After CRT or LVAD therapy, a significant decrease in myocyte size and tumor necrosis factor α (TNF-α) expression compared with healthy controls (P<05) was found. In the CRT group, 6 of 8 patients demonstrated reduction in myocyte size and interstitial fibrosis. In addition, there was a decrease in myocyte size by 13%, total collagen by 27% and TNF-α by 49% in the CRT group vs 28%, 45%, and 45% in the LVAD group. CRT produces cellular reverse remodeling in failing human hearts that are comparable with those produced by LVAD therapy.

AB - Left ventricular assist devices (LVADs) induce reverse cardiac remodeling by reducing myocyte size and collagen deposition. On the other hand, cardiac resynchronization therapy (CRT) induces reverse cardiac remodeling by improving electromechanical synchronization. The clinical and structural changes produced by CRT in failing myocardium are known, but whether these changes are accompanied by reverse cellular remodeling is unknown. A total of 12 patients with chronic heart failure (CHF) who underwent CRT and 15 patients who had LVAD therapy as clinically indicated and 8 healthy controls were compared. Demographics, echocardiographic data, and histologic samples from myocardial biopsies were analyzed and compared among groups. The authors found significant increases in myocyte size, myocardial fibrosis, and inflammation in both CHF groups who underwent CRT or LVAD, compared with healthy controls. After CRT or LVAD therapy, a significant decrease in myocyte size and tumor necrosis factor α (TNF-α) expression compared with healthy controls (P<05) was found. In the CRT group, 6 of 8 patients demonstrated reduction in myocyte size and interstitial fibrosis. In addition, there was a decrease in myocyte size by 13%, total collagen by 27% and TNF-α by 49% in the CRT group vs 28%, 45%, and 45% in the LVAD group. CRT produces cellular reverse remodeling in failing human hearts that are comparable with those produced by LVAD therapy.

UR - http://www.scopus.com/inward/record.url?scp=79957454389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957454389&partnerID=8YFLogxK

U2 - 10.1111/j.1751-7133.2011.00227.x

DO - 10.1111/j.1751-7133.2011.00227.x

M3 - Article

VL - 17

SP - 140

EP - 146

JO - Congestive Heart Failure

JF - Congestive Heart Failure

SN - 1527-5299

IS - 3

ER -